<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FINASTERIDE <img border="0" src="../images/pr.gif"/></span><br/>(fin-as'te-ride)<br/><span class="topboxtradename">Propecia, </span><span class="topboxtradename">Proscar<br/></span><b>Classifications:</b> <span class="classification">hormones &amp; synthetic substitutes</span>; <span class="classification">antiandrogen</span>; <span class="classification">5-alpha reductase inhibitor</span><br/><b>Pregnancy Category: </b>X<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg, 5 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Specific inhibitor of the steroid 5-alpha-reductase, an enzyme necessary to convert testosterone into the potent androgen
         5-alpha-dihydrotestosterone (DHT) in the prostate gland.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Decreases the production of testosterone in the prostate gland.</p>
<h1><a name="uses">Uses</a></h1>
<p>Benign prostatic hypertrophy, male pattern hair loss (androgenetic alopecia).</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to finasteride; pregnancy (category X), lactation, and children.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hepatic impairment, obstructive uropathy.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Benign Prostatic Hypertrophy</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 5 mg/d<br/><br/><span class="indicationtitle">Male Pattern Hair Loss</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1 mg q.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Crush tablets if necessary. Pregnant women should not handle the crushed drug; if absorbed through the skin it may be harmful
            to a male fetus.
         </li>
<li>Store at 15°30° C (59°86° F) unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Urogenital:</span> Impotence, decreased libido, decreased volume of ejaculate. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Depresses levels of <b>DHT</b> and <b>prostate-specific antigen (PSA).</b> <b>Testosterone</b> levels usually are increased.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> No clinically significant interactions established. <span class="typehead">Herbal:</span> <b>Saw palmetto</b> may potentiate effects of finasteride. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 36 mo <span class="typehead">Duration:</span> 57 d. <span class="typehead">Elimination:</span> 39% excreted in urine, 57% in feces. <span class="typehead">Half-Life:</span> 57 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Evaluate carefully any sustained increase in serum PSA levels while patient is taking finasteride. It may indicate the presence
            of prostate cancer or noncompliance with the therapy.
         </li>
<li>Monitor patients with a large residual urinary volume or decreased urinary flow. These patients may not be candidates for
            this therapy.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Use a barrier contraceptive to prevent pregnancy in a sexual partner.</li>
<li>Be aware that impotence and decreased libido may occur with treatment.</li>
<li>Do not breast feed if exposed to this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>